Category Archives: Mylan Pharmaceutical Company

Mylan Doctor Incentives Under Scrutiny

The Guardian revealed on Saturday that Mylan’s CEO, Heather Bresch, sold $5 million of her shares when Mylan released its most recent earnings report. Although the sale was pre-planned through legal channels, Bresch had known since September 2015 that Mylan … Continue reading

Posted in EpiPen Allergy, Mylan Pharmaceutical Company | Leave a comment

Patients Angered by Mylan Deceit

Consumers learned last week that the Mylan pharmaceutical company had increased the cost of its well-known EpiPen allergy emergency epinephrine auto-injector device by 400 percent from $57 in 2007 to $318 last year and now more than $600 this year. … Continue reading

Posted in EpiPen Allergy, Mylan Pharmaceutical Company | Leave a comment